Fast onset
30 seconds in the maxilla, 1 minute for the mandible
Scandonest® 3% plain
3% mepivacaine HCL to provide local anaesthesia without the use of vasoconstrictors for specific clinical situations.
Product License N°: PL 08313/0023
Reactions to Scandonest® are characteristic of those associated with other amide-type local anesthetics. A major cause of adverse reactions to this group of drugs is excessive plasma levels, which may be due to overdosage, inadvertent intravascular injection or slow metabolic degradation. Scandonest® is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of mepivacaine solutions. Local anesthetics should be employed only by clinicians who are well versed in diagnosis and management of dose-related toxicity and other acute emergencies which might arise from the block to be employed, and then only after insuring the immediate availability of oxygen, other resuscitative drugs, cardiopulmonary resuscitative equipment, and the personnel resources needed for proper management of toxic reactions and related emergencies.
30 seconds in the maxilla, 1 minute for the mandible
20 minutes in the maxilla, 40 minutes in the mandible
No natural rubber latex - 0% methylparabens
None of the ingredients of our product Scandonest® 3% plain are an evident source of alcohol.
None of the ingredients of our product Scandonest® 3% plain are an evident source of gluten.
None of the ingredients of our product Scandonest® 3% plain are an evident source of peanut, soy or nut.
Our product Scandonest 30 mg/mL does not contain vasoconstrictor.
Sign up now and get an exclusive access to:
